HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Philip J Mease Selected Research

Fibromyalgia (Fibrositis)

7/2010Pain response profile of patients with fibromyalgia treated with duloxetine.
6/2010Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
12/2009Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors.
11/2009What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine.
9/2009Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.
5/2009Pharmacotherapy of fibromyalgia.
2/2009The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
12/2008Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy?
6/2008Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin.
6/2008Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD

Philip J Mease Research Topics

Disease

22Psoriatic Arthritis
08/2010 - 04/2002
13Fibromyalgia (Fibrositis)
07/2010 - 04/2005
11Rheumatoid Arthritis
05/2010 - 07/2004
11Psoriasis (Pustulosis Palmaris et Plantaris)
02/2010 - 07/2004
9Pain (Aches)
07/2010 - 04/2005
6Arthritis (Polyarthritis)
04/2010 - 05/2002
5Fatigue
09/2009 - 04/2005
4Ankylosing Spondylitis
02/2010 - 03/2007
3Infection
05/2010 - 05/2007
3Inflammation
04/2010 - 04/2002
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2008 - 09/2004
3Skin Manifestations
03/2007 - 10/2005
3Disease Progression
04/2006 - 07/2004
2Histoplasmosis
04/2010 - 07/2009
2Nausea
09/2009 - 02/2009
2Headache (Headaches)
09/2009 - 02/2009
1Infectious Arthritis (Septic Arthritis)
04/2010
1Disease Susceptibility (Diathesis)
02/2010
1Dizziness (Lightheadedness)
09/2009
1Diarrhea
09/2009
1Constipation
09/2009
1Sleep Initiation and Maintenance Disorders (Insomnia)
09/2009
1Mycoses (Diseases, Fungus)
07/2009
1Autoimmune Diseases (Autoimmune Disease)
07/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2008
1Major Depressive Disorder (Major Depressive Disorders)
06/2008
1Spinal Diseases (Disease, Spinal)
05/2007
1Nail Diseases (Nail Disease)
05/2007
1Joint Diseases (Joint Disease)
03/2007
1Opportunistic Infections (Opportunistic Infection)
05/2006
1Respiratory Tract Infections (Respiratory Tract Infection)
04/2006
1Hirsutism
09/2004
1Stomatitis
09/2004
1Acne Vulgaris
09/2004
1Pathologic Processes
05/2003

Drug/Important Bio-Agent (IBA)

10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010 - 04/2002
9adalimumab (Humira)FDA Link
04/2010 - 07/2005
7TNFR-Fc fusion protein (etanercept)FDA Link
06/2010 - 04/2002
6duloxetine (Cymbalta)FDA Link
07/2010 - 06/2008
4rituximab (Mabthera)FDA Link
05/2010 - 01/2008
4Biological Markers (Surrogate Marker)IBA
02/2010 - 08/2009
4Methotrexate (Mexate)FDA LinkGeneric
03/2009 - 05/2006
4Antirheumatic Agents (DMARD)IBA
01/2008 - 07/2004
3milnacipran (Ixel)FDA Link
12/2009 - 10/2005
3Dehydroepiandrosterone (DHEA)IBA
08/2008 - 09/2004
3pregabalin (Lyrica)FDA Link
06/2008 - 04/2005
2ametantrone (HAQ)IBA
06/2010 - 01/2008
2icodextrin (Extraneal)FDA Link
01/2010 - 02/2007
2Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2009 - 02/2009
2Serotonin (5 Hydroxytryptamine)IBA
12/2009 - 02/2009
2alefacept (Amevive)FDA Link
03/2009 - 05/2006
2GlucocorticoidsIBA
08/2008 - 04/2005
2efalizumabFDA Link
03/2007 - 07/2005
1Immunoglobulins (Immunoglobulin)IBA
04/2010
1Immunoglobulin G (IgG)IBA
04/2010
1Deoxyribonucleases (DNase)IBA
04/2010
1dichlorodifluoromethane (FC 12)IBA
04/2010
1leflunomide (Arava)FDA LinkGeneric
04/2010
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
04/2010
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
12/2009
1Neurotransmitter Agents (Neurotransmitter)IBA
12/2009
1Carbon MonoxideIBA
06/2008
1Rheumatoid FactorIBA
05/2007
1Acute-Phase Proteins (Acute-Phase Protein)IBA
05/2007
1C-Reactive ProteinIBA
03/2007
1infliximab (Remicade)FDA Link
07/2005
1CytokinesIBA
04/2002

Therapy/Procedure

5Drug Therapy (Chemotherapy)
08/2010 - 03/2007
1Retreatment
05/2010
1Biological Therapy
11/2005
1Therapeutics
05/2003